Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Hong Kong Island, Hong Kong, China Related Funds
| Fund Name | Location |
| Allin Capital | Changning, China, Shanghai |
| American City Business Journals | Charlotte, North Carolina, United States |
| Anchorage Capital Group L.L.C. | New York, New York, United States |
| BayStar Capital | California, Larkspur, United States |
| Champion Hill Labs | - |
| Fortunetech Investment Fund | - |
| Global Health & Pharma | East Staffordshire, England, United Kingdom |
| Hangzhou Henghua Touzi | China, Hangzhou, Zhejiang |
| Harbinger Ventures | California, Cupertino, United States |
| HBT Holdings | - |
| Junyuan Capital | - |
| Kissei Pharmaceutical | Japan, Matsumoto, Nagano Prefecture |
| National Building and Marketing | Ar Riyad, Riyadh, Saudi Arabia |
| Novell | Provo, United States, Utah |
| PacVen Walden Ventures | China, Hong Kong, Hong Kong Island |
| Sunnybrook Research Institute | - |
| The Road Project | Seattle, United States, Washington |
| Venture Center | India, Maharashtra, Pune |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SiEngine technology | $77M | 28 Feb 2023 | Shanghai, Shanghai, China | ||
B-One | 28 Dec 2022 | New Jersey, United States | |||
ECARX | $65M | 21 Dec 2022 | Shangcheng District, Zhejiang, China | ||
ECARX | $65M | 14 Nov 2022 | Shangcheng District, Zhejiang, China | ||
DEEPEXI | $100M | 20 Aug 2021 | Dongcheng District, Beijing, China | ||
Kyligence | $70M | 20 Apr 2021 | San Jose, California, United States | ||
DEEPEXI | $40M | 05 Dec 2020 | Dongcheng District, Beijing, China | ||
CANbridge Pharmaceuticals | $43M | 01 Dec 2020 | China, Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
